Emergence of generics in the ‘Nexium’ market suffered by modified drugs

Published: 2016-02-12 15:46:45

Updated: 2016-02-12 15:46:45

Patent expiration has completely changed the dynamics of the market of ‘Nexium,’ a peptic ulcer treatment. Both the original and its incrementally modified drugs were not able to avoid downtrends.

The phenomenon is interpreted as a result of the rapid settlement of first generics and second movers in the market in 2014.

Moreover, as Chong Kun Dang joined in the NSAIDs/PPI complex market which...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.